Human Studies vs Animal and Laboratory Research on Adaptogens
What cell and animal studies of adaptogens can and cannot show, why human trials are needed, and how to read headlines that rely on mice, rats or lab dishes.
Content last updated . This page has not been medically reviewed.
Safety first. Supplements can cause side effects and interact with medicines. Read mushroom safety and interactions before you use any mushroom product.
Short answer. Much of the exciting adaptogen research is preclinical, meaning it was done in cells or animals. Those studies can suggest ideas about how a plant might act. They cannot show that a supplement works or is safe for a person. Only studies in people can do that, and the human trials on adaptogens are fewer, smaller and shorter. Nothing in an animal result tells a person what to take; a clinician or pharmacist decides that.
How the sources define the terms
Preclinical research includes experiments on cells in a dish and on animals such as mice and rats. Clinical research tests a preparation in people. The Research Library explains each type in human, animal and laboratory research, and there is a plain comparison in cell studies vs animal studies vs human trials. In this page, "preclinical" always means cells or animals.What the sources found
| Question | What the source found | Our evidence label |
|---|---|---|
| What do animal and cell studies of adaptogens report? | A 2010 review by researchers at a Swedish herbal research institute says studies in animals and isolated nerve cells showed neuroprotective, anti-fatigue, antidepressive, anxiolytic and nootropic activity. [1] | Preclinical (cells or animals) |
| Are the animal results promising? | A 2026 narrative review says preclinical findings are promising, but clinical trials are often limited by small sample sizes, short durations and varied herbal preparations. [2] | Preclinical promising; human evidence limited |
| How many human trials are there? | A 2021 review says that although many people now take plant adaptogens, clinical trials in humans are limited. [3] | Limited |
| Is the way adaptogens work known? | The EMA herbal committee (2008), citing a 1999 review, says the molecular targets responsible for activating DNA and protein synthesis during adaptation are still unknown. [4] | Mechanism not established |
| Do human findings match the lab theory? | Proper evidence not found. We read the reviews listed here and searched PubMed (title or abstract "adaptogen" with randomized controlled trial) on 2026-10-23; we did not find a source that checked animal and human adaptogen results against each other. | Insufficient evidence |
One example shows why the label matters. A 2018 review says Panax ginseng can prolong the life of cancer-bearing mice in animal experiments. [5] That is a mouse finding. It is not evidence that ginseng helps people with cancer, and nothing here should be read that way.
Why animal results often fail to carry over
A 2007 BMJ systematic review compared animal experiments with human trials for six treatments with clear human results. [6] It found that corticosteroids showed benefit in animal models of head injury but not in clinical trials, and that a stroke drug (tirilazad) improved outcomes in animals but was associated with a worse outcome in patients. [6] The authors said the mismatch may be due to bias or to animal models failing to mimic the disease. [6] That review did not study herbs, so it shows the general problem, not the size of the problem for adaptogens.Frequently asked questions
Does a mouse study mean the herb works in people?
No. It is a preclinical finding. It can guide researchers toward a human trial but is not evidence of benefit in people. [6][2]
Why do researchers run animal studies at all?
They can suggest how a plant might act. One 2026 review concludes that further large-scale, standardized clinical studies are needed to confirm efficacy. [2]
Are there human trials of adaptogens?
Yes, for example trials of ashwagandha and rhodiola extracts, but reviews describe them as limited by small size, short duration and varied preparations. [2][9]
Do cell studies show that a supplement is safe?
No. Cell studies do not show how a supplement behaves in a person who also takes medicines or has a liver, kidney, thyroid or autoimmune condition. [8]
How should I read an article that says "research shows"?
Check whether the study was in cells, animals or people; which plant part and extract was used; how many people and for how long; and what was measured. Study limitations and funding lists what to look for.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Limits and uncertainty
- Animals are not people. Animal stress tests are designed by researchers and are not the same as a person's work, sleep or caregiving stress; the BMJ review blames, in part, animal models that do not mimic the disease. [6]
- Cells in a dish are removed from the body. They cannot show what happens in a whole person.
- Plant, part and extract matter. A finding for one extract (for example a root extract of Withania somnifera) does not transfer to a leaf extract or a different species.
- Biomarkers are not outcomes. A change in a lab marker is not the same as feeling or functioning better; see how stress, fatigue and sleep are measured in studies.
- Human trials have their own limits. NCCIH says much of the human research on rhodiola is of low-to-moderate quality. [7]
Safety: what animal studies cannot tell you
References
- Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals (Basel). 2010. PubMed 27713248. Read 2026-10-23.
- Rao YC, Kumari KM, Kateel R, Mohanbabu Vittalrao A. Phyto adaptogens in stress management and health optimization: current understanding and future perspectives. Complement Med Res. 2026. PubMed 42721096. Read 2026-10-23.
- Todorova V, Ivanov K, Delattre C, Nalbantova V, Karcheva-Bahchevanska D, Ivanova S. Plant adaptogens: history and future perspectives. Nutrients. 2021. PubMed 34445021. Read 2026-10-23.
- European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Reflection paper on the adaptogenic concept. EMEA/HMPC/102655/2007, adopted 8 May 2008. Read 2026-10-23.
- Liao LY, He YF, Li L, et al. A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chin Med. 2018. PubMed 30479654, full text at PMC6240259. Read 2026-10-23.
- Perel P, Roberts I, Sena E, et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ. 2007. PubMed 17175568. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Rhodiola: Usefulness and Safety. Page read 2026-10-23. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NIH). Ashwagandha: Usefulness and Safety. Last updated March 2023. Read 2026-10-23.
- Łuszczak J, Kocki J. Clinical evidence for the adaptogenic effects of Withania somnifera and Rhodiola rosea: a systematic review with molecular interpretation of psychometric outcomes. Ann Agric Environ Med. 2026. PubMed 41906501. Read 2026-10-23.